Back
Treatment Options
HIV antiretroviral drug
This is the main treatment for HIV or AIDS. It is not a cure, but it can stop people
from becoming ill for many years. The treatment consists of drugs that have to be
taken every day for the rest of a person’s life.
The aim of antiretroviral treatment is to keep HIV at a low level. This halts weakening
of the immune system and allows it to recover from any damage that HIV might have
caused.
The drugs are often referred to as:
- antiretrovirals.
- anti-HIV
or anti-AIDS drugs.
- HIV antiviral drugs.
- ARVs.
Combination therapy
Taking two or more antiretroviral drugs at a time is called combination therapy.
Taking a combination of three or more anti-HIV drugs is sometimes referred to as
Highly Active Antiretroviral Therapy (HAART).
Importance
If only one drug was taken, HIV would quickly become resistant to it and the drug
would stop working. Taking two or more antiretrovirals at the same time vastly reduces
the rate at which resistance would develop, making treatment more effective in the
long term.
Antiretroviral drugs
There are more than 20 approved antiretroviral drugs but not all are licensed or
available in every country.
There are five groups of antiretroviral drugs. Each of these groups attacks HIV
in a different way.
|
Antiretroviral drug class |
Abbreviations |
First approved to treat HIV |
How they attack HIV |
|
Nucleoside/Nucleotide Reverse Transcriptase Inhibitors |
NRTIs, nucleoside analogues, nukes |
1987 |
NRTIs interfere with the action of an HIV protein called reverse transcriptase,
which the virus needs to make new copies of itself. |
|
Non-Nucleoside Reverse Transcriptase Inhibitors |
NNRTIs, non- nucleosides, non- nukes |
1997 |
NNRTIs also stop HIV from replicating within cells by inhibiting the reverse transcriptase
protein. |
|
Protease Inhibitors |
PIs |
1995 |
PIs inhibit protease, which is another protein involved in the HIV replication process. |
|
Fusion or Entry Inhibitors |
|
2003 |
Fusion or entry inhibitors prevent HIV from binding to or entering human immune
cells. |
|
Integrase Inhibitors |
|
2007 |
Integrase inhibitors interfere with the integrase enzyme, which HIV needs to insert
its genetic material into human cells. |
NRTIs and NNRTIs are available in most countries. Fusion/entry inhibitors and integrase
inhibitors are usually only available in resource- rich countries.
Protease inhibitors are generally less suitable for starting treatment in resource-limited
settings due to the cost, number of pills which need to be taken and the particular
side effects caused by protease drugs.